शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
NGLFINENSENGL Fine-Chem Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 30 Jun, 2025 · 12:58 IST

NGL Fine-Chem Limited has informed the Exchange about Credit Rating- Others

Credit rating downgradedCredit & Debt View source PDFExplain this filing

NGLFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+5.0%Reaction day
₹1049.20
prior close
₹1071.40
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.9%+4.1% vs market
Pharmaceuticals peers, median of 151sector+0.7%+4.3% vs sector

On the reaction day the stock moved 4.1 pts more than Nifty Microcap 250 and 4.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.2
10m
+2.2
15m
+2.5
30m
+2.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+5.0+0.9+4.1+0.7+4.3
Next day
+10.2+0.9+9.3+0.0+10.2
2d
+14.6+0.8+13.8+0.4+14.1
3d
+17.4+0.8+16.6+0.8+16.6
4d
+17.7+1.2+16.5+0.6+17.1
5d
+17.2+0.8+16.5+1.0+16.2
1w
+21.0+1.1+19.9+0.5+20.6
15d
+24.6+2.4+22.2+2.5+22.1
1m
+21.0+0.5+20.6+1.4+19.6
2m
+38.5-2.9+41.4-2.9+41.3
3m
+33.6-4.6+38.2-3.7+37.3
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CRISIL has downgraded NGL Fine-Chem's long-term rating on its bank loan facilities to BBB+/Negative, while reaffirming the short-term rating at A2. The total bank facilities rated amount to Rs. 183.71 crore, spread across HDFC Bank and Kotak Mahindra Bank. The downgrade and negative outlook reflect a moderation in the company's business risk profile due to subdued operating margins and range-bound scale of operations. The rating action is based on a CRISIL letter dated June 27, 2025, and disclosed to the exchanges on June 30, 2025.

Likely market impact

Negative for shareholders — the rating cut and negative outlook signal weakening profitability and business outlook, which could raise borrowing costs and weigh on investor sentiment in the near term.